Efficacy and safety of belimumab in lupus nephritis patients: a real-world observational study in China
BACKGROUND: This study aimed to describe disease activity, clinical outcome and overall patterns of lupus nephritis care in patients who received belimumab in a real-world clinical setting in China. MATERIALS AND METHODS: This observational cohort study included lupus nephritis patients who received...
Main Authors: | Meng Tan, Jing Xu, Ying Tan, Zhen Qu, Feng Yu, Minghui Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2023-02-01
|
Series: | Kidney Diseases |
Online Access: | https://www.karger.com/Article/FullText/529675 |
Similar Items
-
Efficacy and safety of belimumab therapy in lupus nephritis: a systematic review and meta-analysis
by: Han Zhang, et al.
Published: (2023-12-01) -
Prospects for the use of belimumab in lupus nephritis
by: N. L. Kozlovskaya, et al.
Published: (2021-08-01) -
Belimumab for systemic lupus erythematosus – Focus on lupus nephritis
by: Marlene Plüß, et al.
Published: (2022-11-01) -
Effectiveness and Safety of Belimumab in Chinese Lupus Patients: A Multicenter, Real-World Observational Study
by: Fangfang Sun, et al.
Published: (2023-03-01) -
Urine proteomic insights from the belimumab in lupus nephritis trial
by: Daniel Goldman, et al.
Published: (2022-10-01)